Could NORD/NIH/NCATS help underwrite this technology for all rare disease PAOs? Second question: once have tokenized datasets how can we easily assess data quality/standardization?
I wish. We need to prove out the model with a few datasets before others can fund this. There is general alignment and interest but no specific action yet towards funding this.
tokenization only touches a subset of the data, so there will be additional work to assess quality
Could NORD/NIH/NCATS help underwrite this technology for all rare disease PAOs? Second question: once have tokenized datasets how can we easily assess data quality/standardization?
I wish. We need to prove out the model with a few datasets before others can fund this. There is general alignment and interest but no specific action yet towards funding this.
tokenization only touches a subset of the data, so there will be additional work to assess quality